Have a personal or library account? Click to login
Delayed Diagnoses of SGCE Myoclonus-Dystonia Cover

Delayed Diagnoses of SGCE Myoclonus-Dystonia

Open Access
|Jul 2020

References

  1. 1Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, Bertram M, et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet. 2001; 29(1): 669. DOI: 10.1038/ng709
  2. 2Roze E, Apartis E, Clot F, Dorison N, Thobois S, Guyant-Marechal L, et al. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology. 2008; 70(13): 10106. DOI: 10.1212/01.wnl.0000297516.98574.c0
  3. 3Timmers ER, Smit M, Kuiper A, Bartels AL, van der Veen S, van der Stouwe AMM, et al. Myoclonus-dystonia: Distinctive motor and non-motor phenotype from other dystonia syndromes. Parkinsonism & related disorders. 2019; 69: 8590. DOI: 10.1016/j.parkreldis.2019.10.015
  4. 4Peall KJ, Dijk JM, Saunders-Pullman R, Dreissen YE, van Loon I, Cath D, et al. Psychiatric disorders, myoclonus dystonia and SGCE: an international study. Ann Clin Transl Neurol. 2016; 3(1): 411. DOI: 10.1002/acn3.263
  5. 5Koukouni V, Valente EM, Cordivari C, Bhatia KP, Quinn NP. Unusual familial presentation of epsilon-sarcoglycan gene mutation with falls and writer’s cramp. Movement disorders: official journal of the Movement Disorder Society. 2008; 23(13): 19135. DOI: 10.1002/mds.21935
  6. 6Multani N, Moro E, Lang A, Zurowski M, Duff Canning S, Tartaglia MC. Progression of neuropsychiatric and cognitive features due to exons 2 to 5 deletion in the epsilon-sarcoglycan gene: a case report. Neurocase. 2016; 22(2): 2159. DOI: 10.1080/13554794.2015.1120312
  7. 7Raymond D, Saunders-Pullman R, de Carvalho Aguiar P, Schule B, Kock N, Friedman J, et al. Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations. Movement disorders: official journal of the Movement Disorder Society. 2008; 23(4): 58892. DOI: 10.1002/mds.21785
  8. 8Roze E, Lang AE, Vidailhet M. Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment. Curr Opin Neurol. 2018; 31(4): 48490. DOI: 10.1097/WCO.0000000000000577
  9. 9Drivenes B, Born AP, Ek J, Dunoe M, Uldall PV. A child with myoclonus-dystonia (DYT11) misdiagnosed as atypical opsoclonus myoclonus syndrome. Eur J Paediatr Neurol. 2015; 19(6): 71921. DOI: 10.1016/j.ejpn.2015.07.010
  10. 10Zutt R, van Egmond ME, Elting JW, van Laar PJ, Brouwer OF, Sival DA, et al. A novel diagnostic approach to patients with myoclonus. Nat Rev Neurol. 2015; 11(12): 68797. DOI: 10.1038/nrneurol.2015.198
  11. 11Tian XJ, Ding CH, Zhang YH, Dai LF, Chen CH, Li JW, et al. [Clinical and genetic analysis of childhood-onset myoclonus dystonia syndrome caused by SGCE variants]. Zhonghua Er Ke Za Zhi. 2020; 58(2): 1238.
  12. 12Lumsden DE, Gimeno H, Tustin K, Kaminska M, Lin JP. Interventional studies in childhood dystonia do not address the concerns of children and their carers. Eur J Paediatr Neurol. 2015; 19(3): 32736. DOI: 10.1016/j.ejpn.2015.01.003
  13. 13Kosutzka Z, Tisch S, Bonnet C, Ruiz M, Hainque E, Welter ML, et al. Long-term GPi-DBS improves motor features in myoclonus-dystonia and enhances social adjustment. Movement disorders: official journal of the Movement Disorder Society. 2019; 34(1): 8794. DOI: 10.1002/mds.27474
  14. 14Luciano AY, Jinnah HA, Pfeiffer RF, Truong DD, Nance MA, LeDoux MS. Treatment of myoclonus-dystonia syndrome with tetrabenazine. Parkinsonism & related disorders. 2014; 20(12): 14236. DOI: 10.1016/j.parkreldis.2014.09.029
  15. 15Hainque E, Vidailhet M, Cozic N, Charbonnier-Beaupel F, Thobois S, Tranchant C, et al. A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia. Neurology. 2016; 86(18): 172935. DOI: 10.1212/WNL.0000000000002631
  16. 16Moro E, LeReun C, Krauss JK, Albanese A, Lin JP, Walleser Autiero S, et al. Efficacy of pallidal stimulation in isolated dystonia: a systematic review and meta-analysis. Eur J Neurol. 2017; 24(4): 55260. DOI: 10.1111/ene.13255
  17. 17Xiao J, Nance MA, LeDoux MS. Incomplete nonsense-mediated decay facilitates detection of a multi-exonic deletion mutation in SGCE. Clinical genetics. 2013; 84(3): 27680. DOI: 10.1111/cge.12059
  18. 18Springer A, Dyck Holzinger S, Andersen J, Buckley D, Fehlings D, Kirton A, et al. Profile of children with cerebral palsy spectrum disorder and a normal MRI study. Neurology. 2019; 93(1): e88e96. DOI: 10.1212/WNL.0000000000007726
DOI: https://doi.org/10.5334/tohm.334 | Journal eISSN: 2160-8288
Language: English
Submitted on: May 13, 2020
Accepted on: May 17, 2020
Published on: Jul 28, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 M. Georgeta Varga, Nikita P. Nand, Mark S. LeDoux, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.